You are here
- Home
- Last 30 days trials
A Phase I, Open-Label, 3-way Crossover, Pharmacokinetic and Drug-Drug Interaction Study of ceftazidime avibactam (CAZ-AVI) and Metronidazole when Administered Alone and in Combination in Healthy Subjects
- Disease
- drug safety, pharmacokinetics
- Drug Name
- CAZ-104
- Generic Name
- CAZ -AVI
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Feb 17, 2012
- Study Name
- D4280C00012
- Study Id
- D4280C00012
- ClinicalTrials.gov ID
- NCT01534247
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
